Patents by Inventor Rainer Landgraf

Rainer Landgraf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160279204
    Abstract: The present invention provides peptides for use in a medicament which is administered nasally, wherein the peptide is an agonist of neuropeptide S receptor (NPSR), of the receptor TGR23 and/or of vasopressin receptor-related receptor 1 (VRR1) or for use in the treatment of a patient by causing, promoting or increasing relieve or healing of phobic anxiety, avoidance anxiety, dis-sociative anxiety such as flashbacks, depersonalisation, derealisation, intrusions, vegetative symptoms related to anxiety symptoms, especially in panic attacks, in posttraumatic stress disorder, in generalised anxiety disorder and in anxiety accompanying depressive, or psychotic episodes, arousal, awakening, alertness, activity, spontaneous movement, an anxiolytic effect or a combination thereof in the patient, wherein the peptide is administered nasally or for use in the prophylaxis and/or treatment of an anxiety or sleep dis-order, especially in any type of hypersomnia like idiopathic hypersomnia, wherein the peptide is administered
    Type: Application
    Filed: March 25, 2015
    Publication date: September 29, 2016
    Applicant: MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFT E.V.
    Inventors: Yi-Chun YEN, Axel STEIGER, Florian HOLSBOER, Rainer LANDGRAF, Irina Alexandra IONESCU, Ulrike SCHMIDT
  • Publication number: 20140249090
    Abstract: The present invention provides peptides for use in a medicament which is administered nasally, wherein the peptide is an agonist of neuropeptide S receptor (NPSR), of the receptor TGR23 and/or of vasopressin receptor-related receptor 1 (VRR1) or for use in the treatment of a patient by causing, promoting or increasing relieve or healing of phobic anxiety, avoidance anxiety, dissociative anxiety such as flashbacks, depersonalization, derealization, intrusions, vegetative symptoms related to anxiety symptoms, especially in panic attacks, in posttraumatic stress disorder, in generalised anxiety disorder and in anxiety accompanying depressive, or psychotic episodes, arousal, awakening, alertness, activity, spontaneous movement, an anxiolytic effect or a combination thereof in the patient, wherein the peptide is administered nasally or for use in the prophylaxis and/or treatment of an anxiety or sleep disorder, especially in any type of hypersomnia like idiopathic hypersomnia, wherein the peptide is administered n
    Type: Application
    Filed: April 2, 2012
    Publication date: September 4, 2014
    Applicant: MAX-PLANCK-GESELLSCHAFT ZUR FĂ–RDERUNG DER WISSENSCHAFT E.V.
    Inventors: Yi-Chun Yen, Axel Steiger, Florian Holsboer, Rainer Landgraf, Irina Alexandra Ionescu, Ulrike Schmidt
  • Patent number: 6343329
    Abstract: In a method for communicating information from e-mails which are intended for a subscriber of a telecommunication network and are filed in an e-mail service, subsequent to the activation of a corresponding service, e-mail messages arriving in the e-mail service for the subscriber are at least partially converted into speech, forwarded to a voice mail service and loaded there as a spoken message. In a suitable telecommunication system, an e-mail/voice mail converter is provided, which is arranged for the at least partial conversion of e-mail messages into speech and/or speech into digital written form, a control logic being provided for the actuation of the converter by comma nd messages of a subscriber.
    Type: Grant
    Filed: December 21, 1998
    Date of Patent: January 29, 2002
    Assignee: Siemens Aktiengesellschaft
    Inventors: Rainer Landgraf, Manfred Reich